PEA (Palmitoylethanolamide)
Affiliate link: we may earn a commission at no extra cost to you. Disclosures
PEA (Palmitoylethanolamide). Endogenous fatty acid amide for pain and inflammation.
How it works. Activates PPAR-α and indirect CB receptors.
What the research supports. 1 graded claims. Strongest: Reduces neuropathic pain (moderate).
How much to take. Typical dose: 600 mg BID.
Side effects and interactions. 1 medication interaction listed. No serious side effects listed at normal doses.
Stacking. Pairs well with Vitamin D3 + K2, Zinc.
Common forms. Available as Capsule or softgel, Powder, Sublingual or buccal, Liposomal liquid.
Key studies. 8 studies cited. The strongest are listed with links to PubMed.
Community. Experiences from people who have tried PEA (Palmitoylethanolamide). Anecdotes are not medical advice.
PEA (Palmitoylethanolamide). Endogenous fatty acid amide for pain and inflammation.
What it is
Endogenous fatty acid amide for pain and inflammation.
Food sources
Goals
How it works
Activates PPAR-α and indirect CB receptors.
Pathways
- Activates PPAR-α
- indirect CB receptors
Effects
- ↓neuropathic pain decreases
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
As an Amazon Associate I earn from qualifying purchases. Look for USP, NSF or Informed Sport seals before you buy.
Side effects & interactions
Common side effects
- GI upset
Medication interactions
Always disclose PEA (Palmitoylethanolamide) use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- Vitamin D3 + K2Foundational immune modulation.
- ZincRequired cofactor for innate and adaptive immune function.
Common forms
- Capsule or softgel
- Powder
- Sublingual or buccal
- Liposomal liquid
Key studies
8 studies cited in total.
Significant pain reduction across conditions.
Opens current human and preclinical literature matching PEA (Palmitoylethanolamide) and "Reduces neuropathic pain". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching PEA (Palmitoylethanolamide) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.
Discussion
Loading discussion…